Annual report [Section 13 and 15(d), not S-K Item 405]

Note 12 - Stockholders' Equity (Tables)

v3.26.1
Note 12 - Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
               

Shares Subject to Purchase

 

Exercise Price per Share

   

Expiration Date

   

at December 31, 2025

 
$ 275.00       07/17/2028       1,819  
$ 250.00       08/04/2028       1,029  
$ 97.50       05/14/2029       3,913  
$ 78.00       05/14/2029       100,625  
$ 19.30       12/19/2029       42,500  
$ 19.20       12/19/2029       32,500  
$ 11.34       10/16/2030       1,133,794  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Year ended December 31,

 
   

2025

   

2024

 

Cost of product sales

  $ 32     $ 217  

Research and development cost

    150       48  

General and administrative expense

    2,093       2,472  

Total

  $ 2,275     $ 2,737  
Share-based Payment Arrangement, Option and Restricted Stock Unit, Activity [Table Text Block]
           

PSUs Outstanding

   

RSUs Outstanding

 
                   

Weighted-

           

Weighted-

 
   

Number of

           

Average

           

Average

 
   

Shares

           

Grant Date

           

Grant Date

 
   

Available for

   

Number of

   

Fair Value

   

Number of

   

Fair Value

 
   

Grant

   

PSUs

   

Per Share

   

RSUs

   

Per Share

 

Balance at December 31, 2023

    7,102       2,376     $ 112.50       40,896     $ 172.00  

Granted

    (98,748 )     15,882       21.50       82,866       14.80  

Released

                      (17,764 )     165.40  

Forfeited

    18,829       (240 )     (112.50 )     (18,589 )     71.60  

Returned to Plan

    5,225                          

Addition to 2019 Plan

    47,500                          

Expiration of 2014 Plan

    (3,152 )                        

Balance at December 31, 2024

    (23,244 )     18,018       32.30       87,409       32.90  

Granted

    (247,875 )     11,847       8.08       236,028       8.08  

Released

          (11,847 )     34.49       (64,617 )     34.49  

Forfeited

    29,360       (6,140 )     (33.99 )     (23,220 )     15.79  

Returned to Plan

    19,508                          

Addition to 2019 Plan

    260,000                          

Balance at December 31, 2025

    37,749       11,878     $ 31.42       235,600     $ 15.17  
           

Weighted-

 
           

Average

 
           

Grant Date

 
   

Number of

   

Fair Value

 
   

Shares

   

Per Share

 

Outstanding at January 1, 2025

    10,077     $ 36.40  

Forfeited

    (4,060 )      

Outstanding at December 31, 2025

    6,017     $ 36.40  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
   

2024

   

2023

 

Volatility

    88.03 %     91.40 %

Risk-free interest rate

    4.26 %     4.30 %
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
           

Weighted-

 
           

Average

 
           

Grant Date

 
   

Number of

   

Fair Value

 
   

Shares

   

Per Share

 

Outstanding at January 1, 2025

    7,941     $ 29.30  

Forfeited

    (2,080 )      

Outstanding at December 31, 2025

    5,861     $ 29.30  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Number of Shares

 

Equity Plan

       

Subject to outstanding options and restricted shares

    247,478  

Available for future grants

    37,749  

Officer and Director Purchase Plan

    237,382  

Warrants

    1,316,180  

2022 Employee Stock Purchase Plan

    731,220  

Total reserved shares

    2,570,009